Gregory F. Murphy voted YEA on 100% of tracked bills classified as favoring Pharmaceuticals & Biotech and Real Estate, ranking #29 among House members on this metric. For example, he voted YEA on HR3537-117, classified as favoring pharmaceutical access, though he voted YEA on 3 of 4 bills classified as limiting these same sectors.
FOLLOW THE TRAIL
How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated July 3, 2026 · internal signal score 86/100.